Impact of objective response and overall survival in patients with inoperable or metastatic gastric and esophagogastric junction (EGJ) cancer: Landmark analysis of 10 year data from first-line clinical trials

被引：0
|
作者：
Bolt, T. A. [1 ]
Pauligk, C. [1 ]
Werner, D. [1 ]
Mayer, F. [2 ]
Hofheinz, R. [3 ]
Nils, H. [4 ]
Luley, K. [5 ]
Schmalenberg, H. [6 ]
Egger, M. [7 ]
Al-Batran, S-E. [1 ]
机构：
[1] Krankenhaus Norwest, Inst Klin Onkol Forsch, Frankfurt, Germany
[2] Univ Med Ctr, Tubingen, Germany
[3] Univ Med Ctr, Dept Hematol & Med Oncol, Mannheim, Germany
[4] Klinikum Wolfsburg, Wolfsburg, Germany
[5] Univ Klinikum Lubeck, Lubeck, Germany
[6] Univ Tumorctr Jena, Jena, Germany
[7] Ortenau Klinikum, Lahr Ettenheim, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [21] PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials
    Francini, Edoardo
    Petrioli, Roberto
    Rossi, Giulia
    Laera, Letizia
    Roviello, Giandomenico
    TUMOR BIOLOGY, 2014, 35 (11) : 10601 - 10607
  • [22] Effects of taxanes alone or in combination with anthracyclines on tumor response, progression-free survival and overall survival in first-line chemotherapy of patients with metastatic breast cancer: an analysis of 4,256 patients randomized in 12 trials
    Piccart, MJ
    Burzykowski, T
    Sledge, G
    Carmichael, J
    Luck, HJ
    Mackey, JR
    Nabholtz, JM
    Paridaens, R
    Biganzoli, L
    Jassem, J
    Blohmer, JU
    Bontenbal, M
    Bonneterre, J
    Chan, S
    Atalay, G
    Therasse, P
    Buyse, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S278 - S279
  • [23] Surrogate end points for median overall survival in metastatic colorectal cancer: Literature-based analysis from 39 Randomized controlled trials of first-line chemotherapy
    Tang, Patricia A.
    Bentzen, Soren M.
    Chen, Eric X.
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4562 - 4568
  • [24] Effect of the addition of bevacizumab to first-line FOLFOX on efficacy, including response rate, progression-free survival, and overall survival, in patients with metastatic colorectal cancer
    Suenaga, M.
    Mizunuma, N.
    Matsusaka, S.
    Shinozaki, E.
    Ogura, M.
    Kuboki, Y.
    Watanabe, T.
    Ozaka, M.
    Chin, K.
    Hatake, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials
    You, Xia-Hong
    Jiang, Yu-Huan
    Fang, Zhou
    Sun, Fan
    Li, Yao
    Wang, Wei
    Xia, Zi-Jin
    Wang, Xiao-Zhong
    Ying, Hou-Qun
    ESMO OPEN, 2020, 5 (02)
  • [26] Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database
    Shi, Qian
    de Gramont, Aimery
    Grothey, Axel
    Zalcberg, John
    Chibaudel, Benoist
    Schmoll, Hans-Joachim
    Seymour, Matthew T.
    Adams, Richard
    Saltz, Leonard
    Goldberg, Richard M.
    Punt, Cornelis J. A.
    Douillard, Jean-Yves
    Hoff, Paulo M.
    Hecht, Joel Randolph
    Hurwitz, Herbert
    Diaz-Rubio, Eduardo
    Porschen, Rainer
    Tebbutt, Niall C.
    Fuchs, Charles
    Souglakos, John
    Falcone, Alfredo
    Tournigand, Christophe
    Kabbinavar, Fairooz F.
    Heinemann, Volker
    Van Cutsem, Eric
    Bokemeyer, Carsten
    Buyse, Marc
    Sargent, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 22 - U47
  • [27] Evaluation of two-dimensional response to predict overall survival in patients with metastatic colorectal cancer treated with the first-line bevacizumab-based chemotherapy
    Nakayama, Goro
    Takano, Nao
    Tanaka, Chie
    Kobayashi, Daisuke
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [28] Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials
    Som, A.
    Tu, S-M
    Liu, J.
    Wang, X.
    Qiao, W.
    Logothetis, C.
    Corn, P. G.
    BRITISH JOURNAL OF CANCER, 2012, 107 (09) : 1547 - 1553
  • [29] Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials
    A Som
    S-M Tu
    J Liu
    X Wang
    W Qiao
    C Logothetis
    P G Corn
    British Journal of Cancer, 2012, 107 : 1547 - 1553
  • [30] First-line chemotherapy analysis on survival in carcinoma ovary patients: Data from a Northern Indian cancer center
    Dogra, Atika
    Talwar, Vineet
    Goel, Varun
    Sekhon, Rupinder
    Rawal, Sudhir Kumar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1589 - 1596
12345